Products / Onchology y Oncohematology

Drifen

Paclitaxel 30-150 mg

Paclitaxel is indicated for ovarian cancer, breast cancer and lung cancer.

Therapeutic Action

Antineoplastic

Presentations

1 vial x 5-25 ml

Drifen Paclitaxel 30-150 mg de Laboratorios Richmond
Download Prospect

Legal Notice

Products which continue to have a valid patent protection at present are manufactured in line with the current laws of the Argentine Republic. Please, take into account that our products will only be shipped to countries where the substance and its use are not protected by patents.

Laboratorios Richmond S.A.C.I.F. Argentina © All rights reserved Terms of use